Bausch Health to Announce First Quarter Results on April 30

ACCESS Newswire

03-27

LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.

Conference Call Details

Date:		Wednesday, April 30, 2025

Time:		5:00 p.m. U.S. EDT

Webcast:		http://ir.bauschhealth.com/events-and-presentations

A replay of the conference call will be available on the investor relations website.

About Bausch Health

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.

Investor Contact:		Media Contact:
Garen Sarafian		Katie Savastano
ir@bauschhealth.com		corporate.communications@bauschhealth.com
(877) 281-6642 (toll-free)		(908) 541-3785

SOURCE: Bausch Health Companies Inc

View the original press release on ACCESS Newswire

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2522365379"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2522365379\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2522365379?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-03-27 19:00","share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","id":"2522365379","market":"us","top_or_hot":-1,"title":"Bausch Health to Announce First Quarter Results on April 30","media":"ACCESS Newswire","content":"<html><body><p><strong>LAVAL, QC / ACCESS Newswire / March 27, 2025 / </strong><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.</p>\n<p><strong>Conference Call Details</strong></p>\n<figure>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td><p><span>Date:</span></p></td>\n<td></td>\n<td><p><span>Wednesday, April 30, 2025</span></p></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td><p><span>Time:</span></p></td>\n<td></td>\n<td><p><span>5:00 p.m. U.S. EDT</span></p></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td><p><span>Webcast:</span></p></td>\n<td></td>\n<td><p>http://ir.bauschhealth.com/events-and-presentations</p></td>\n</tr>\n</tbody>\n</table>\n</figure>\n<p>A replay of the conference call will be available on the investor relations website.</p>\n<p><strong>About Bausch Health</strong></p>\n<p>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.</p>\n<figure>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td><p><strong>Investor Contact:</strong></p></td>\n<td></td>\n<td><p><strong>Media Contact:</strong></p></td>\n</tr>\n<tr>\n<td><p>Garen Sarafian</p></td>\n<td></td>\n<td><p>Katie Savastano</p></td>\n</tr>\n<tr>\n<td><p>ir@bauschhealth.com</p></td>\n<td></td>\n<td><p>corporate.communications@bauschhealth.com</p></td>\n</tr>\n<tr>\n<td><p>(877) 281-6642 (toll-free)</p></td>\n<td></td>\n<td><p>(908) 541-3785</p></td>\n</tr>\n</tbody>\n</table>\n</figure>\n<p><strong>SOURCE: </strong>Bausch Health Companies Inc</p>\n<br/>\n<br/>View the original \npress release on ACCESS Newswire\n<br/>\n<br/></body></html>","source":"yahoofinance","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bausch Health to Announce First Quarter Results on April 30</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBausch Health to Announce First Quarter Results on April 30\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">ACCESS Newswire</strong><span class=\"h-time small\">2025-03-27 19:00</span>\n</p>\n</h4>\n</header>\n<article>\n<html><body><p><strong>LAVAL, QC / ACCESS Newswire / March 27, 2025 / </strong><a href=\"https://laohu8.com/S/BHC\">Bausch Health Companies Inc</a>. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.</p>\n<p><strong>Conference Call Details</strong></p>\n<figure>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td><p><span>Date:</span></p></td>\n<td></td>\n<td><p><span>Wednesday, April 30, 2025</span></p></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td><p><span>Time:</span></p></td>\n<td></td>\n<td><p><span>5:00 p.m. U.S. EDT</span></p></td>\n</tr>\n<tr>\n<td></td>\n<td></td>\n<td></td>\n</tr>\n<tr>\n<td><p><span>Webcast:</span></p></td>\n<td></td>\n<td><p>http://ir.bauschhealth.com/events-and-presentations</p></td>\n</tr>\n</tbody>\n</table>\n</figure>\n<p>A replay of the conference call will be available on the investor relations website.</p>\n<p><strong>About Bausch Health</strong></p>\n<p>Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.</p>\n<figure>\n<table width=\"100%\">\n<tbody>\n<tr>\n<td><p><strong>Investor Contact:</strong></p></td>\n<td></td>\n<td><p><strong>Media Contact:</strong></p></td>\n</tr>\n<tr>\n<td><p>Garen Sarafian</p></td>\n<td></td>\n<td><p>Katie Savastano</p></td>\n</tr>\n<tr>\n<td><p>ir@bauschhealth.com</p></td>\n<td></td>\n<td><p>corporate.communications@bauschhealth.com</p></td>\n</tr>\n<tr>\n<td><p>(877) 281-6642 (toll-free)</p></td>\n<td></td>\n<td><p>(908) 541-3785</p></td>\n</tr>\n</tbody>\n</table>\n</figure>\n<p><strong>SOURCE: </strong>Bausch Health Companies Inc</p>\n<br/>\n<br/>View the original \npress release on ACCESS Newswire\n<br/>\n<br/></body></html>\n<div class=\"bt-text\">\n\n\n<p> 來源：<a href=\"https://finance.yahoo.com/news/bausch-health-announce-first-quarter-110000009.html\">ACCESS Newswire</a></p>\n<p>為提升您的閱讀體驗，我們對本頁面進行了排版優化</p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"製藥","start_time":0,"source_url":"https://finance.yahoo.com/news/bausch-health-announce-first-quarter-110000009.html","article_id":"2522365379","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2522365379","pubTimestamp":1743073200,"columns":[],"sourceInfo":{"source_id":"yahoofinance","name":"雅虎金融"},"weMediaInfo":null,"summary":"A replay of the conference call will be available on the investor relations website.","collect":0,"end_time":0,"defaultTopTitle":"yahoo.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","BHC":"Bausch Health Companies Inc"},"translate_title":"博士生健康将于4月30日公布第一季度业绩","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BHC":0.9},"content_text":"LAVAL, QC / ACCESS Newswire / March 27, 2025 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) will release first quarter financial results after market close on Wednesday, April 30, 2025. Bausch Health will host a conference call and live webcast at 5:00 p.m. U.S. EDT to discuss the results and provide a business update. All materials will be made available on the Investor Relations section of the Bausch Health website prior to the start of the call.\nConference Call Details\n\n\n\n\nDate:\n\nWednesday, April 30, 2025\n\n\n\n\n\n\n\nTime:\n\n5:00 p.m. U.S. EDT\n\n\n\n\n\n\n\nWebcast:\n\nhttp://ir.bauschhealth.com/events-and-presentations\n\n\n\n\nA replay of the conference call will be available on the investor relations website.\nAbout Bausch Health\nBausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) is a global diversified pharmaceutical company enriching lives through our relentless drive to deliver better health care outcomes. We develop, manufacture and market a range of products primarily in gastroenterology, hepatology, neurology, dermatology, dentistry, aesthetics, international pharmaceuticals and eye health, through our controlling interest in Bausch + Lomb. Our ambition is to be a globally integrated healthcare company, trusted and valued by patients, HCPs, employees and investors. For more information, visit www.bauschhealth.com and connect with us on LinkedIn.\n\n\n\n\nInvestor Contact:\n\nMedia Contact:\n\n\nGaren Sarafian\n\nKatie Savastano\n\n\nir@bauschhealth.com\n\ncorporate.communications@bauschhealth.com\n\n\n(877) 281-6642 (toll-free)\n\n(908) 541-3785\n\n\n\n\nSOURCE: Bausch Health Companies Inc\n\nView the original \npress release on ACCESS Newswire","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}